AFFIMER
LIVE

Serial Number

79154375

Owner

Avacta Limited

Attorney

Christina M. Licursi

Filing Date

Jan 7, 2014

Add to watchlist:

No watchlists yet
View on USPTO

AFFIMER Trademark

Serial Number: 79154375 • Registration: 4975232

AFFIMER is a trademark filed by Avacta Limited on January 7, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Avacta Limited (7 trademarks)

Wetherby LS237FA , GB

Entity Type: 99

Trademark Details

Filing Date

January 7, 2014

Registration Date

June 14, 2016

Published for Opposition

May 26, 2015

Goods & Services

Reagents for use in veterinary and medical diagnostic tests, except tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except screening in the field of immunohematology and transfusion medicine; diagnostic reagents for use in assays of biological samples, particularly blood, except in the field of immunohematology and transfusion medicine; diagnostic reagents for use in assays of samples, particularly blood, except in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screening, except screening in the field of immunohematology and transfusion medicine; diagnostic preparations for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies and products comprising them, all for use in medical and/or veterinary screening, except screening in the field of immunohematology and transfusion medicine; [ antigens for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigens, except preparations in the field of immunohematology and transfusion medicine; substrates impregnated with or carrying antigens for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; ] affinity reagents equivalent to antibodies for diagnostic and/or pharmaceutical purposes other than immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents equivalent to antibodies, except in connection with immunohematology or transfusion medicine; substrates impregnated with or carrying affinity reagents equivalent to antibodies for pharmaceutical purposes other than immunohematology or transfusion medicine [ ; wound dressings medical plasters; antiseptic wipes; diagnostic agents for medical use except in connection with immunohematology and transfusion medicine, containing any of the aforesaid products ]

Reagents for use in scientific research; reagents for use in scientific screening

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Jul 18, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 1, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jul 1, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 1, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 1, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 1, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 1, 2025 COAR
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Jun 14, 2025 REM4
PARTIAL INVALIDATION PROCESSED BY THE IB
Apr 15, 2024 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Mar 12, 2024 INPS
INVALIDATION PROCESSED
Mar 12, 2024 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 3, 2024 INPR
INTERNATIONAL REGISTRATION RENEWED
Feb 1, 2024 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 3, 2023 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 3, 2023 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 3, 2023 APRE
TEAS SECTION 71 RECEIVED
Dec 14, 2022 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 14, 2021 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jun 7, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 11, 2019 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Dec 1, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 12, 2016 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 21, 2016 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2016 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 14, 2016 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 1, 2016 OPNX
REGISTERED-PRINCIPAL REGISTER
Jun 14, 2016 R.PR
TTAB RELEASE CASE TO TRADEMARKS
May 11, 2016 TMBN
OPPOSITION TERMINATED NO. 999999
May 11, 2016 OP.T
OPPOSITION DISMISSED NO. 999999
May 11, 2016 OP.D
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 6, 2016 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 6, 2016 OPNR
REFUSAL PROCESSED BY IB
Oct 9, 2015 RFNP
OPPOSITION INSTITUTED NO. 999999
Sep 24, 2015 OP.I
OPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Sep 23, 2015 OPNS
OPPOSITION NOTICE (IB REFUSAL) CREATED
Sep 23, 2015 OPNC
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 24, 2015 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2015 PUBO
NOTIFICATION PROCESSED BY IB
May 22, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 6, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 6, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 17, 2015 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2015 CRFA
ASSIGNED TO LIE
Apr 14, 2015 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 9, 2015 TROA
REFUSAL PROCESSED BY IB
Dec 5, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 19, 2014 RFCS
REFUSAL PROCESSED BY MPU
Nov 19, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 18, 2014 RFCR
APPLICATION FILING RECEIPT MAILED
Nov 18, 2014 MAFR
NON-FINAL ACTION WRITTEN
Nov 17, 2014 CNRT
ASSIGNED TO EXAMINER
Nov 12, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 12, 2014 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 6, 2014 REPR